Pathology of the hereditary colorectal carcinoma
Authors:
- 13 June 2007
- journal article
- review article
- Published by Springer Nature in Familial Cancer
- Vol. 7 (1) , 15-26
Abstract
Positive familial history (first or second degree relative) for colorectal carcinoma (CRC) can be found in approximately 30% of all newly diagnosed cases, but less than 5% will be due to a defined genetic category of hereditary CRC. Pathologic examination of the biopsy or resection specimen can help in identification of unsuspected cases of certain forms of hereditary CRC due to the characteristic morphologic findings. Additional immunohistochemical and molecular studies can then provide a definitive diagnosis. The most common form of hereditary CRC is Lynch syndrome (hereditary non-polyposis colorectal cancer, HNPCC) which is characterized by proximally located tumors frequently showing mucinous and medullary type histologic features. The syndrome results from a germline mutation in genes for mismatch repair (MMR) proteins leading to insufficient DNA repair and development of tumors characterized by high levels of instability in short tandem repeat DNA sequences (microsatellites) or “microsatellite instability-high” (MSI-H). The presence of intra-epithelial lymphocytes is single most helpful morphologic feature in identification of CRC caused by deficiency in MMR proteins, for which MSI-H status is a good marker but morphologic features and MSI-H do not differentiate tumors caused by germline mutations in one of the MMR genes (Lynch syndrome) from sporadic CRC due to inactivation of MLH-1 through promoter methylation. Hereditary CRC may also arise in various familial polyposis syndromes which include familial adenomatous polyposis (FAP), attenuated FAP and other multiple adenomas syndromes as well as various hamartomatous polyposis syndromes. All of these rare conditions have characteristic clinical presentation and histopathologic features of polyps and most of them have defined genetic abnormality. Furthermore, due to the germline nature of mutations in these syndromes, various extracolonic manifestations may be the first sign of the disease and knowledge of such associations can greatly improve the quality of care for these patients. The role of pathologist is to recognize these characteristics and initiate appropriate follow up with clinicians and genetic counselors.Keywords
This publication has 90 references indexed in Scilit:
- The Case for a Genetic Predisposition to Serrated Neoplasia in the Colorectum: Hypothesis and Review of the LiteratureCancer Epidemiology, Biomarkers & Prevention, 2006
- Hyperplastic Polyposis Syndrome: Phenotypic Presentations and the Role of MBD4 and MYHGastroenterology, 2006
- CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancerNature Genetics, 2006
- Desmoid Tumors – a Characterization of Patients Seen at Mayo Clinic 1976–1999Familial Cancer, 2006
- ASGE guideline: colorectal cancer screening and surveillanceGastrointestinal Endoscopy, 2006
- An Ancestral Ashkenazi Haplotype at the HMPS/CRAC1 Locus on 15q13–q14 Is Associated with Hereditary Mixed Polyposis SyndromeThe American Journal of Human Genetics, 2003
- Hereditary intestinal cancerSeminars in Cancer Biology, 2000
- Prospective blinded trial of the colonoscopic miss-rate of large colorectal polypsGastrointestinal Endoscopy, 1991
- Cronkhite-Canada syndrome: Radiologic featuresGastrointestinal Radiology, 1989
- Cowden's disease (multiple hamartoma and neoplasia syndrome)Journal of the American Academy of Dermatology, 1983